| Surgen12 vs King | 37–22 | 62.71% |
| Surgen12 vs Heihachi | 19–34 | 35.85% |
| Surgen12 vs Hwoarang | 31–14 | 68.89% |
| Surgen12 vs Dragunov | 27–17 | 61.36% |
| Surgen12 vs Steve | 19–22 | 46.34% |
| Surgen12 vs Law | 17–15 | 53.12% |
| Surgen12 vs Jin | 15–17 | 46.88% |
| Surgen12 vs Bryan | 20–12 | 62.50% |
| Surgen12 vs Reina | 17–12 | 58.62% |
| Surgen12 vs Paul | 9–15 | 37.50% |
| Surgen12 vs Yoshimitsu | 11–13 | 45.83% |
| Surgen12 vs Kazuya | 15–8 | 65.22% |
| Surgen12 vs Eddy | 11–12 | 47.83% |
| Surgen12 vs Azucena | 12–9 | 57.14% |
| Surgen12 vs Raven | 10–8–1 | 55.56% |
| Surgen12 vs Lili | 7–11 | 38.89% |
| Surgen12 vs Leo | 6–12 | 33.33% |
| Surgen12 vs Xiaoyu | 9–7 | 56.25% |
| Surgen12 vs Victor | 9–6 | 60.00% |
| Surgen12 vs Lidia | 9–6 | 60.00% |
| Surgen12 vs Asuka | 4–10 | 28.57% |
| Surgen12 vs Lars | 8–5 | 61.54% |
| Surgen12 vs Nina | 8–5 | 61.54% |
| Surgen12 vs Lee | 6–7 | 46.15% |
| Surgen12 vs Zafina | 3–8 | 27.27% |
| Surgen12 vs Devil Jin | 7–3 | 70.00% |
| Surgen12 vs Kuma | 6–4 | 60.00% |
| Surgen12 vs Feng | 8–1 | 88.89% |
| Surgen12 vs Claudio | 5–4 | 55.56% |
| Surgen12 vs Leroy | 6–3 | 66.67% |
| Surgen12 vs Jack-8 | 5–3 | 62.50% |
| Surgen12 vs Alisa | 4–4 | 50.00% |
| Surgen12 vs Shaheen | 3–5 | 37.50% |
| Surgen12 vs Jun | 5–3 | 62.50% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.